Cellectis SA (CLLS)
4.62
-0.12
(-2.53%)
USD |
NASDAQ |
Dec 08, 16:00
4.40
-0.22
(-4.76%)
After-Hours: 20:00
Cellectis EPS Diluted (Quarterly): 0.0058 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| EDAP TMS SA | -0.1565 |
| DBV Technologies SA | -1.207 |
| Genfit SA | -- |
| Ascendis Pharma A/S | -1.173 |
| Akari Therapeutics Plc | -0.1948 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.5864M |
| Revenue (Quarterly) | 35.02M |
| Total Expenses (Quarterly) | 34.43M |
| Enterprise Value | 390.50M |
| Gross Profit Margin (Quarterly) | 85.76% |
| Profit Margin (Quarterly) | 1.67% |
| Earnings Yield | -7.21% |
| Normalized Earnings Yield | -6.662 |